中国现代应用药学
中國現代應用藥學
중국현대응용약학
CONTENTS IN BRIEF
2001年
1期
27-29
,共3页
沈赞聪%崔纯莹%张强%魏树礼
瀋讚聰%崔純瑩%張彊%魏樹禮
침찬총%최순형%장강%위수례
胰岛素气雾剂%降血糖作用%药理生物利用度%大鼠
胰島素氣霧劑%降血糖作用%藥理生物利用度%大鼠
이도소기무제%강혈당작용%약리생물이용도%대서
目的:研究胰岛素气雾剂经肺部给药后的降血糖作用。方法:建立了大鼠的肺部给药模型,通过经口吸入及气管内给药两种途径将溶液型胰岛素气雾剂导入大鼠肺内,采用葡萄糖氧化酶法测定给药后正常大鼠及糖尿病大鼠的血糖水平,并计算其药理生物利用度。结果:在同一种剂量下,经口吸入和气管内给药两种途径在正常及糖尿病大鼠体内均呈现显著的降血糖作用。其药理生物利用度在正常大鼠体内分别为6.0%和11.4%,在糖尿病大鼠体内分别为5.6%和8.7%。结论:胰岛素气雾剂能有效地降低正常及糖尿病大鼠血糖,为进一步开发临床治疗糖尿病的新剂型打下基础。
目的:研究胰島素氣霧劑經肺部給藥後的降血糖作用。方法:建立瞭大鼠的肺部給藥模型,通過經口吸入及氣管內給藥兩種途徑將溶液型胰島素氣霧劑導入大鼠肺內,採用葡萄糖氧化酶法測定給藥後正常大鼠及糖尿病大鼠的血糖水平,併計算其藥理生物利用度。結果:在同一種劑量下,經口吸入和氣管內給藥兩種途徑在正常及糖尿病大鼠體內均呈現顯著的降血糖作用。其藥理生物利用度在正常大鼠體內分彆為6.0%和11.4%,在糖尿病大鼠體內分彆為5.6%和8.7%。結論:胰島素氣霧劑能有效地降低正常及糖尿病大鼠血糖,為進一步開髮臨床治療糖尿病的新劑型打下基礎。
목적:연구이도소기무제경폐부급약후적강혈당작용。방법:건립료대서적폐부급약모형,통과경구흡입급기관내급약량충도경장용액형이도소기무제도입대서폐내,채용포도당양화매법측정급약후정상대서급당뇨병대서적혈당수평,병계산기약리생물이용도。결과:재동일충제량하,경구흡입화기관내급약량충도경재정상급당뇨병대서체내균정현현저적강혈당작용。기약리생물이용도재정상대서체내분별위6.0%화11.4%,재당뇨병대서체내분별위5.6%화8.7%。결론:이도소기무제능유효지강저정상급당뇨병대서혈당,위진일보개발림상치료당뇨병적신제형타하기출。
OBJECTIVE:To study the hypoglycemic effects of insulin aerosol(INS-AOL) by pulmonary delivery.METHOD:The animal model for pulmonary delivery was established in rats.INS-AOL was delivered by oral inhalation or intratracheal administration in normal and diabetic rats.Blood glucose levels were examined employing the glucose oxidase method.The pharmacological bioavailabilities were calculated by trapezoidal method.RESULTS:When delivered to normal or diabetic rats,INS-AOL significantly reduced blood glucose level by inhalation as well as intratracheal administration.In normal rats,the pharmacological bioavailability reached 6.0% by inhalation and 11.4% by intratracheal delivery.And in diabetic rats,the pharmacological bioavailability reached 5.6% and 8.7%,respectively.CONCLUSION:Results indicated that INS-AOL is effective in reducing blood glucose in normal or diabetic rats.This study would be helpful for the development of a new insulin preparation for the treatment of diabetics.